Inventor
Maninder Hora
Inventor
Danville, CA, US
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
B01DSeparation7%
B01LChemical or physical laboratory apparatus for general use7%
C07CAcyclic or carbocyclic compounds7%
C12NMicroorganisms or enzymes7%
C07KPeptides4%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for3%
A23PShaping or working of foodstuffs, not fully covered by a single other subclass3%
B82YSpecific uses or applications of nanostructures3%
PatentTitleYear
11,077,186Methods for preparing squalene202110,517,947Methods for preparing squalene20199,867,877'Methods for preparing squalene'20189,545,440'Methods for preparing squalene'20179,199,897'Methods for preparing squalene'20158,333,958'HSA-free formulations of interferon-Beta'20127,892,531'HSA-free formulations of interferon-β'20117,846,479'Microparticle compositions and methods for the manufacture thereof'20107,807,142'Stabilized liquid polypeptide-containing pharmaceutical compositions'20107,662,369'Stabilized interferon compositions'20107,399,463'HSA-free formulations of interferon-beta'20087,371,373'HSA-free formulations of interferon-β'20087,335,639'IGF-1 composition and its use'20087,226,757'Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor'20077,067,485'IGF-I composition and its use'20067,030,086'Stabilized liquid polypeptide-containing pharmaceutical compositions'20066,994,847'Stabilized interferon compositions'20066,887,462'HSA-free formulations of interferon-beta'20056,753,015'Microparticle compositions and methods for the manufacture thereof'20046,573,238'Method for producing sustained-release formulations'20036,525,102'Stabilized liquid polypeptide-containing pharmaceutical compositions'20036,319,896'Method of solubilizing, purifying, and refolding protein'20016,306,432'High and low load formulations of IGF-I in multivesicular liposomes'20015,997,856'Method and compositions for solubilization and stabilization of polypeptides, especially proteins'19995,888,968'TFPI formulation'19995,730,969'Method and compositions for solubilization and stabilization of polypeptides, especially proteins'19985,078,997'Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers'1992Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1992–1999Based in Rodeo, CA, US· patent location history
1998–2006Patents assigned to CHIRON CORP (12)· patent assignee history
1999–2012Based in Danville, CA, US· patent location history
2007–2012Patents assigned to NOVARTIS VACCINES & DIAGNOSTIC (8)· patent assignee history
2010–2021Patents assigned to NOVARTIS AG (6)· patent assignee history
2012–2015Patents assigned to HORA MANINDER (2)· patent assignee history
2012Patents assigned to BABUKA SUSAN (1)· patent assignee history
2015Based in Pleasanton, CA, US· patent location history
2017–2021Based in East Hanover, NJ, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHIRON CORP | 12 | 1998–2006 |
| NOVARTIS VACCINES & DIAGNOSTIC | 8 | 2007–2012 |
| NOVARTIS AG | 6 | 2010–2021 |
| HORA MANINDERself | 2 | 2012–2015 |
| BABUKA SUSAN | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Danville, California, US | 19 | 1999–2012 |
| East Hanover, New Jersey, US | 4 | 2017–2021 |
| Rodeo, California, US | 3 | 1992–1999 |
| Pleasanton, California, US | 1 | 2015 |